ストックスクリーナーアプリを入手
0.6544
0.93%
0.006
プレマーケット:
.63
-0.0244
-3.73%
前日終値:
$0.6484
開ける：
$0.645
24時間の取引高:
43,699
Relative Volume:
0.21
時価総額：
$50.40M
収益：
$234.00K
当期純損益:
$-23.11M
株価収益率:
-0.6358
EPS:
-1.0292
ネットキャッシュフロー:
$-20.71M
1週間 パフォーマンス:
-0.06%
1か月 パフォーマンス:
+1.14%
6か月 パフォーマンス:
-6.91%
1年 パフォーマンス:
-53.26%
1日の値動き範囲:
$0.645
$0.6649
1週間の範囲:
$0.621
$0.6783
52週間の値動き範囲:
$0.3625
$1.89
Envoy Medical Inc Stock (COCH) Company Profile
名前
Envoy Medical Inc
セクター
電話
651-361-8000
住所
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COCH
Envoy Medical Inc
|
0.6544 | 49.69M | 234.00K | -23.11M | -20.71M | -1.0292 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-31 | 開始されました | H.C. Wainwright | Buy |
| 2024-06-24 | 開始されました | Ascendiant Capital Markets | Buy |
Envoy Medical Inc (COCH) 最新ニュース
Envoy Medical Inc. (COCH) Q1 2026 Earnings: EPS Surprise Beats Estimates, but Stock Declines Amid Missing RevenueGuidance Upgrade Report - newsline.com
Envoy Medical, Inc. Class A Financial Disclosures & SEC Filings - TradingView
Envoy Medical (COCH) registers 15.12M shares from warrants, $20.1M if cashed - Stock Titan
New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA - ACCESS Newswire
New to The Street Broadcasting Saturday June 13th 630pm Est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA - Moomoo
COCH Q1 2026 Earnings: Narrower Loss Beats EstimatesBanking Earnings Report - newsline.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Envoy Medical Inc. (COCH) Q1 2026 Earnings: EPS Surprises to the Upside, Revenue Not ReportedEarnings Beat Alert - newsline.com
New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET - newswire.com
Envoy Medical (COCH) Slips Over 3% as Bearish Pressure Intensifies – Support Test LoomsBollinger Expansion - newsline.com
COCH Q1 2026 Earnings: Loss Narrower Than Expected as Pre-Revenue Company Advances PipelineLow Growth Earnings - newsline.com
Envoy Medical (COCH) CEO adds ESPP shares and reports large warrant, option holdings - Stock Titan
Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th - marketscreener.com
Hearing implant developer Envoy Medical heads to Vegas investor conference - Stock Titan
Envoy Medical (NASDAQ:COCH) Signs Multi-Part Series With New to The Street - Black Hills Pioneer
Envoy Medical (NASDAQ: COCH) Signs Multi-Part Series With New to The Street - marketscreener.com
Envoy Medical (COCH) Holds Steady Near Support as Penny Stock Seeks DirectionIsland Reversal - newsline.com
COCH Q1 2026 Earnings: EPS Surprise Beats Estimates Amid Pre-Revenue StageEarnings Decline Risk - The Legal Advocate
Envoy Medical Inc Warrant (COCHW) Holds Steady at $0.06 Amid Minimal TradingFade Trade - newsline.com
Envoy Medical (COCH) Slips Slightly as Traders Eye Key Support at $0.66Gamma Flip Level - The Legal Advocate
Envoy Medical Inc Warrants (COCHW) Hold Steady at $0.06 as Trading Activity Remains SubduedOvernight Profile - The Legal Advocate
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology - Florida Hospital News and Healthcare Report
COCH Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SurpriseLow Estimate Range - Newser
Envoy Medical Granted Extension to Regain Nasdaq Compliance - The Globe and Mail
COCH Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Progress, Though Revenue Absence Raises QuestionsHigh Growth Earnings - Newser
Envoy Medical Inc. (COCH) Q1 2026 Earnings: Strong EPS Beat Amidst Pre-Revenue StageEarnings Per Share - Newser
Envoy Medical Q1 2026 Earnings: EPS Surprises to the Upside Despite No Revenue, Stock DeclinesTrading Community Hub - Newser
COCH Q1 2026 Earnings: Significant EPS Beat Amid Revenue UncertaintyElite Trading Signals - Newser
Envoy Medical Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Envoy Medical (NASDAQ: COCH) granted more time to meet Nasdaq $1 bid rule - Stock Titan
COCH Q1 2026 Earnings: Narrower Loss Beats Estimates as Envoy Medical AdvancesReturn On Assets - Newser
COCH Q1 2026 Earnings: EPS Beats Estimates Despite Pre-Revenue Status, Stock DeclinesShared Buy Zones - Newser
Daily Penny AlertsEnvoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology - FinancialContent
4 new patents push fully implanted hearing tech at Envoy Medical - Stock Titan
Envoy Medical shareholders approve plan amendments and board elections at annual meeting By Investing.com - Investing.com South Africa
Envoy Medical shareholders approve plan amendments and board elections at annual meeting - Investing.com Australia
Envoy Medical Shareholders Expand Equity and Governance Plans - TipRanks
Envoy Medical (NASDAQ: COCH) holders back larger equity and stock purchase plans - Stock Titan
Envoy Medical (COCH): Nantahala reports 9.99% position in company - Stock Titan
[SCHEDULE 13G] Envoy Medical, Inc. Passive Investment Disclosure (>5%) - Stock Titan
Envoy Medical Flags Limited Risk Detail, Urges Investors to Review 2026 Form 10-K for Key Uncertainties - The Globe and Mail
TradingKey - TradingKey
Envoy Medical, Inc. Q1 2026 Financial Report: Earnings, Balance Sheet, and FDA-Approved Hearing Devices Overview - Minichart
ENVOY MEDICAL (COCH) insiders report 2.46M warrants, 3.10% stake - Stock Titan
Envoy Medical completes pivotal trial enrollment, raises $78m By Investing.com - Investing.com South Africa
Envoy Medical Achieves Pivotal Trial Milestone and Secures $78M Financing for Fully Implanted Cochlear Implant FDA Approval Progress - Minichart
Envoy Medical completes pivotal trial enrollment, raises $78m - Investing.com
Envoy Medical, Inc. 1Q 2026: Revenue $39K, Net income ($5.7M), EPS ($0.08) — 10-Q Summary - TradingView
Envoy Medical Inc (COCH) 財務データ
収益
当期純利益
現金流量
EPS
Envoy Medical Inc (COCH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Potashnick Robert | Interim CFO |
Feb 12 '26 |
Buy |
0.40 |
212,500 |
85,000 |
212,500 |
| Kantor Susan | Director |
Feb 12 '26 |
Buy |
0.40 |
96,150 |
38,460 |
174,037 |
| BRYNELSEN CHARLES | Director |
Feb 12 '26 |
Buy |
0.40 |
1,000,000 |
400,000 |
1,050,000 |
| Lucas Brent T. | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.40 |
62,500 |
25,000 |
297,090 |
| TAYLOR GLEN A | 10% Owner |
Feb 12 '26 |
Buy |
0.40 |
18,750,000 |
7,500,000 |
21,703,607 |
2.43%
大文字化:
|
ボリューム (24 時間):